Medication info
Enerbi Tablets (Citrulline Malate)

Enerbi Tablets (Citrulline Malate)

OTC medicationTabletOral
Ingredient · strength
Citrulline Malate›500mg / 1 tablet
Manufacturer / importer
Youngil Pharmaceutical Co., Ltd.
Appearance
Orange oval film-coated tablets
Packaging
Bottle packaging - 42 tablets/bottle, bottle packaging - 84 tablets/bottle, bottle packaging - 180 tablets/bottle, bottle packaging - 500 tablets/bottle
Approval status
Active

MFDS item code 202400123 · Approved 2024.01.17

Summary

Main use
Adjunctive treatment of functional asthenia
Who takes it
Adults · Children
Adult dose
Adults: Take 2 tablets per dose, 3 times daily, as citrulline malate. Do not administer for more than 4 weeks.
Child dose
Children (6 years and older): Take 2 tablets per dose, twice daily, as citrulline malate.

Ingredients

Manufacturer
Youngil Pharmaceutical Co., Ltd.

Efficacy & effects

Adjunctive treatment of functional asthenia

  • Functional paralysis
View approved original text

This medication used for the adjunctive treatment of functional paralysis helps strengthen muscle power and alleviate symptoms. It supports muscle function improvement alongside primary treatment, contributing to enhanced daily living activities for patients. This increases overall treatment efficacy and prevents symptom exacerbation. It is used as an adjunctive treatment for functional paralysis.

How to take

Adult dose

Adults: Take 2 tablets per dose, 3 times daily, as citrulline malate. Do not administer for more than 4 weeks.

Child dose

Children (6 years and older): Take 2 tablets per dose, twice daily, as citrulline malate.

Precautions

It is advisable not to administer this medication to children under the age of 6. Pregnant women are advised not to take this medication. While animal studies have not reported teratogenic effects, the safety of administration during pregnancy is not well established. Lactating women are also advised against taking this medication due to insufficient data on its excretion in breast milk. If symptoms do not improve after one month of taking this medication, it is important to consult a doctor or pharmacist immediately. This medication contains the pigments Yellow No. 203 (Quinoline Yellow WS) and Yellow No. 5 (Sunset Yellow FCF). Individuals with allergies or hypersensitivity to these components should take caution when using this medication. It is crucial to adhere to the prescribed dosage and usage, and children should take the medicine under the supervision of an adult. Mild gastrointestinal disturbances may occur rarely at the beginning of treatment, which should be noted. This medication should be stored in a safe place out of reach of children and kept tightly closed in its original container. Transferring it to another container may cause misuse or degradation of quality.

Side effects

Mild gastrointestinal disorder

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it must be stored in a tightly sealed container. Additionally, avoid storing in excessively hot or cold places, and it is safest to store it at room temperature between 1°C and 30°C.

Appearance and packaging

Appearance

Orange oval film-coated tablets

Package unit

Bottle packaging - 42 tablets/bottle, bottle packaging - 84 tablets/bottle, bottle packaging - 180 tablets/bottle, bottle packaging - 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.